(Q28572971)

31 January 2017

title

Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction (English)

1 reference

31 January 2017

1 reference

Yan-Xia Wang

1

1 reference

31 January 2017

Ying-Jiong Ding

2

1 reference

31 January 2017

Yi-Zhun Zhu

3

1 reference

31 January 2017

Ying Shi

4

1 reference

31 January 2017

Tai Yao

5

1 reference

31 January 2017

Yi-Chun Zhu

6

1 reference

31 January 2017

publication date

1 January 2007

1 reference

American Journal of Physiology Heart and Circulatory Physiology

31 January 2017

published in

1 reference

31 January 2017

volume

292

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

H348–359

1 reference

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Endothelin in cardiovascular disease: from atherosclerosis to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Urotensin II evokes potent vasoconstriction in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Congestive heart failure and expression of myocardial urotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Cardiovascular effects of urotensin II in anesthetized and pithed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Arrestin-independent internalization and recycling of the urotensin receptor contribute to long-lasting urotensin II-mediated vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Calcium-dependent and calcium-independent contractions in smooth muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Alternative pathways of angiotensin II production in the human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Serotonin transporter mechanisms and cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Mechanisms of hydroxyl radical-induced contraction of rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Plasma urotensin in human systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Relation between muscarinic receptor cationic current and internal calcium in guinea-pig jejunal smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Mechanism of human urotensin II-induced contraction in rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Endothelial dysfunction in aortic rings and mesenteric beds isolated from deoxycorticosterone acetate hypertensive rats: possible involvement of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

The role of urotensin II in cardiovascular and renal physiology and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

Interleukin-3 Stimulates Migration and Proliferation of Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00512.2006

10.1152/AJPHEART.00512.2006

21 January 2018

Identifiers

DOI

1 reference

31 January 2017

1 reference